Perioperative complications in liver transplantation using donation after cardiac death grafts: A propensity-matched study

Liver Transplantation

Volumn 20, Issue 7, 2014, Pages 823-830

  Pan, Xiongxiong ^a,b   Apinyachon, Worapot ^a   Xia, Wei ^a   Hong, Johnny C ^c   Busuttil, Ronald W ^a   Steadman, Randolph H ^a   Xia, Victor W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HYPERTENSIVE FACTOR;

ADULT; ADVERSE OUTCOME; AGED; ANESTHESIOLOGY; ARTICLE; BLOOD; BRAIN DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ENDOTRACHEAL INTUBATION; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART ARREST; HEART DEATH; HEART VENTRICLE TACHYCARDIA; HEPATITIS C; HUMAN; HYPERKALEMIA; HYPOTENSION; INSTITUTIONAL REVIEW; KIDNEY INJURY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PERFUSION; LIVER TRANSPLANTATION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTREPERFUSION COMPLICATION; POSTREPERFUSION SYNDROME; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; DONOR; END STAGE LIVER DISEASE; MIDDLE AGED; PERIOPERATIVE PERIOD; PROCEDURES; PROSPECTIVE STUDY; TRANSPLANTATION; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BRAIN DEATH; END STAGE LIVER DISEASE; FEMALE; HUMANS; HYPERKALEMIA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903128858     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23888     Document Type: Article

References (31)

1. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, et al. OPTN/SRTR 2011 annual data report: liver. Am J Transplant 2013; 13 (suppl 1): 73-102.
2. Merion RM,. What can we learn from discarded deceased donor kidneys? Transplantation 2006; 81: 973.
3. DeOliveira ML, Jassem W, Valente R, Khorsandi SE, Santori G, Prachalias A, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg 2011; 254: 716-722.
4. Broomhead RH, Patel S, Fernando B, O'Beirne J, Mallett S,. Resource implications of expanding the use of donation after circulatory determination of death in liver transplantation. Liver Transpl 2012; 18: 771-778.
5. Hong JC, Yersiz H, Kositamongkol P, Xia VW, Kaldas FM, Petrowsky H, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg 2011; 146: 1017-1023.
6. Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87-92.
7. Braat AE, Blok JJ, Putter H, Adam R, Burroughs AK, Rahmel AO, et al.; for European Liver and Intestine Transplant Association (ELITA) and Eurotransplant Liver Intestine Advisory Committee (ELIAC). The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant 2012; 12: 2789-2796.
8. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al.; for European Liver Transplant Association. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367: 225-232.
9. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, et al. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl 2011; 17: 641-649.
10. Leithead JA, Tariciotti L, Gunson B, Holt A, Isaac J, Mirza DF, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant 2012; 12: 965-975.
11. Croome KP, Wall W, Chandok N, Beck G, Marotta P, Hernandez-Alejandro R,. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl 2013; 19: 1214-1223.
12. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
13. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-753.
14. Hong JC, Koroleff D, Xia V, Chang CM, Duarte SM, Xu J, et al. Regulated hepatic reperfusion mitigates ischemia-reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. J Am Coll Surg 2012; 214: 505-515.
15. Tan WF, Steadman RH, Farmer DG, Hong JC, Busuttil RW, Apinyachon W, Xia VW,. Pretransplant neurological presentation and severe posttransplant brain injury in patients with acute liver failure. Transplantation 2012; 94: 768-774.
16. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791-796.
17. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM,. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010; 10: 2512-2519.
18. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR,. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82: 1683-1688.
19. Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744-753.
20. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl 2009; 15: 1028-1035.
21. Callaghan CJ, Charman SC, Muiesan P, Powell JJ, Gimson AE, van der Meulen JH,;, for UK, Liver Transplant Audit. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open 2013; 3: e003287.
22. van der Hilst CS, Ijtsma AJ, Bottema JT, van Hoek B, Dubbeld J, Metselaar HJ, et al. The price of donation after cardiac death in liver transplantation: a prospective cost-effectiveness study. Transpl Int 2013; 26: 411-418.
23. Pine JK, Aldouri A, Young AL, Davies MH, Attia M, Toogood GJ, et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl 2009; 15: 1072-1082.
24. Rubin DB,. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127 (pt 2): 757-763.
25. Xia VW, Ghobrial RM, Du B, Chen T, Hu KQ, Hiatt JR, et al. Predictors of hyperkalemia in the prereperfusion, early postreperfusion, and late postreperfusion periods during adult liver transplantation. Anesth Analg 2007; 105: 780-785.
26. Cameron A, Busuttil RW,. AASLD/ILTS transplant course: is there an extended donor suitable for everyone? Liver Transpl 2005; 11 (suppl 2): S2-S5.
27. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504-508.
28. Ryu HG, Jung CW, Lee HC, Cho YJ,. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation. Liver Transpl 2012; 18: 1430-1439.
29. De Wolf A, Frenette L, Kang Y, Tang C,. Insulin decreases the serum potassium concentration during the anhepatic stage of liver transplantation. Anesthesiology 1993; 78: 677-682.
30. Xia VW, Obaidi R, Park C, Braunfeld M, Neelakanta G, Nourmand H, et al. Insulin therapy in divided doses coupled with blood transfusion versus large bolus doses in patients at high risk for hyperkalemia during liver transplantation. J Cardiothorac Vasc Anesth 2010; 24: 80-83.
31. Fukazawa K, Pretto EA,. The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function. J Hepatobiliary Pancreat Sci 2011; 18: 406-413.